Secondary Malignant Neoplasm — Trials

Secondary Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

14,658 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4,270
Recruiting: 2,317
Ph III recruiting: 269
Growth YoY: +14%
Industry share: 22%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,960)

clinicaltrialsPublishedShowing 1–50 of 14,658 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00001276	Diagnosing and Treating Low Blood Sugar Levels	recruiting	—	1,500	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH	1	Sep 28, 2026	clinicaltrials
NCT00646022	Natural History of Familial Carcinoid Tumor	recruiting	—	1,600	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH	1	Sep 28, 2026